Gong Xiaomei, Chief Physician, Professor, Doctor of Oncology (Ph.D. & M.D.), Doctoral Supervisor and Postdoctoral Supervisor at Tongji University. Selected for the Shanghai Talent Development Plan, the Outstanding Backbone Program of Shanghai Pulmonary Hospital, and a member of the Shanghai Outstanding Talent Pool. Member and Secretary of the Youth Committee of the Shanghai Medical Association's Radiation Oncology Branch; Member of the Stereotactic Radiotherapy Committee of the China Lung Cancer Prevention and Treatment Alliance; Member of the Radiation Oncology Committee of the China Medical Education Association; Member of the Lung Cancer Medical Education Committee of the China Medical Education Association; Member of the Brain Metastasis Tumor Committee of the Shanghai Anti-Cancer Association; Member of the Shanghai Women Physicians Association; Member of the Youth Committee of the Radiotherapy Committee of the Shanghai Anti-Cancer Association. Leading a team with long-term dedication to basic and clinical research on lung cancer, with research directions including tumor radioresistance, regulation of the tumor immune microenvironment, radiation-induced injury, artificial intelligence and precision radiotherapy, and nanomedicine delivery. Possessing extensive clinical experience, specializing in the early diagnosis of pulmonary nodules, ground-glass opacities, and lung cancer, as well as comprehensive treatments such as radiotherapy, immunotherapy, targeted therapy, and concurrent chemoradiotherapy for lung cancer. Invited annually to deliver academic presentations at the World Conference on Lung Cancer, European Lung Cancer Congress, and American Lung Cancer Conference. With advanced treatment concepts and remarkable efficacy, widely praised by domestic and international peers, demonstrating medical benevolence and meticulous patient care. Principal investigator of 2 National Natural Science Foundation of China projects, 5 Shanghai Science and Technology Commission projects, and 3 Shanghai Health Commission projects. Previously participated in major research initiatives such as the Ministry of Education's "Changjiang Scholars and Innovative Research Team Development Plan." Published over 30 academic papers as first/corresponding author in domestic and international professional journals, including more than 20 SCI-indexed papers. Holds 3 national invention patents and received one third-class award for Shanghai Medical Science and Technology. Co-authored two books: *New Comprehensive Treatment of Lung Cancer* (Tongji University Press) and *Biological Targeted Therapy for Lung Cancer* (People's Medical Publishing House).